The rise of GLP-1s has transformed Eli Lilly—and the pharma industry as a whole. We explain why investors now value the company more like a tech giant than a drugmaker https://t.co/KY3LKd7U4O ...

Industry Outlook - Pharmaceutical industry remains a significant distance away from the total elimination of diseases despite advancements in technology [1] AI Integration in Drug Discovery - AI's current impact on drug discovery is viewed with cautious realism by industry leadership, noting that the technology has not yet reached a stage to eradicate diseases [1]